Skip to main content.

Remaking Health Care

This column explores how health reform is changing the ways in which we pay for and deliver health care in the U.S. It also highlights the ways in which our current system is falling short on measures of coverage, access and affordability. On any given week, that could mean a look at how Republican plans to repeal Obamacare could reshape the individual insurance market, how the safety net system is adapting to new financial pressures, or how the trend of doctors and hospitals merging into ever-larger entities is driving up costs. We also explore health care costs and whether the Affordable Care Act or its successor plans can live up to the promise to rein them in. Throughout, we keep watch on how the goals of health reform intersect with the shaping power of markets and human behavior. Contributors include veteran health journalist Trudy Lieberman and independent health journalist Kellie Schmitt, with occasional contributions from independent journalists such as Susan Abram and Sara Stewart.

Picture of Trudy  Lieberman
If drug price negotiation fails, Democrats lose funding for much of their current health care plans.
Picture of Kellie  Schmitt
New research has some surprising findings that challenge old assumptions about Medicaid.
Picture of Trudy  Lieberman
While hospitals often deflect blame to other sectors of health care, there’s no question they play an outsized role in rising costs.
Picture of Mark Kreidler
As the Delta variant rages, caregivers face dual battles against the virus and burnout.
Picture of Deb Gordon
As the COVID-19 crisis continues, insurers begin to restrict coverage for remote care. Never mind that patients love it.
Picture of Trudy  Lieberman
The media has largely taken a pass on covering the dark side of Medicare Advantage plans, so people don't understand how the plans’ cost-sharing and provider networks really work.
Picture of Giles Bruce
The backlash goes in the face of decades of research that has found syringe exchanges reduce the transmission of disease and help get people off drugs.
Picture of Trudy  Lieberman
The media, the medical community, and academic drug experts all quickly questioned the FDA’s approval process — a rare occurrence.
Picture of Trudy  Lieberman
Plans for adding a public option to the Affordable Care Act have stalled as the president punts the issue to Congress.
Picture of Trudy  Lieberman
Holdout states are turning to some surprising tactics to keep voter-led pushes for Medicaid expansion off the table.

Pages

Announcements

Our California Impact Fund offers mentorship and support to reporters who think big and want to make a difference in their communities through investigative or explanatory reporting on promising approaches to chronic ills. 

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth